Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Change in Cash (2017 - 2026)

Kiniksa Pharmaceuticals International filings provide 6 years of Change in Cash readings, the most recent being $24.4 million for Q1 2026.

  • On a quarterly basis, Change in Cash rose 192.09% to $24.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $32.8 million, a 104.44% increase, with the full-year FY2025 number at -$18.0 million, down 123.78% from a year prior.
  • Change in Cash hit $24.4 million in Q1 2026 for Kiniksa Pharmaceuticals International, up from -$9.3 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $86.2 million in Q4 2024 to a low of -$59.1 million in Q1 2022.
  • Median Change in Cash over the past 5 years was -$1.9 million (2024), compared with a mean of $4.0 million.
  • Biggest five-year swings in Change in Cash: tumbled 1116.6% in 2022 and later soared 973.05% in 2024.
  • Kiniksa Pharmaceuticals International's Change in Cash stood at -$53.0 million in 2022, then surged by 81.39% to -$9.9 million in 2023, then soared by 973.05% to $86.2 million in 2024, then tumbled by 110.74% to -$9.3 million in 2025, then skyrocketed by 362.97% to $24.4 million in 2026.
  • The last three reported values for Change in Cash were $24.4 million (Q1 2026), -$9.3 million (Q4 2025), and -$17.2 million (Q3 2025) per Business Quant data.